Detalhe da pesquisa
1.
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.
Breast Cancer Res
; 25(1): 117, 2023 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794508
2.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902335
3.
The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.
Int J Cancer
; 151(4): 616-622, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403708
4.
Oligometastases: Incorporate the patient perspective to ensure optimal treatment and care.
J Surg Oncol
; 129(4): 679-680, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100164
5.
Survival and prognostic factors in oligometastatic breast cancer.
Breast
; 67: 14-20, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549169
6.
Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation.
Fam Cancer
; 22(2): 151-154, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112334
7.
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.
JCO Precis Oncol
; 7: e2200670, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738542
8.
Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer.
JNCI Cancer Spectr
; 5(3)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33977227
9.
Prognostic factors in patients with oligometastatic breast cancer - A systematic review.
Cancer Treat Rev
; 91: 102114, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33161237
10.
Adjuvant chemotherapy in small node-negative triple-negative breast cancer.
Eur J Cancer
; 135: 66-74, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554215
11.
Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.
Eur J Heart Fail
; 22(2): 338-346, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696625
12.
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 6(4): 528-534, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999296
13.
Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore.
Clin Cancer Res
; 25(16): 4985-4992, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076546
14.
Consideration of breast cancer subtype in targeting the androgen receptor.
Pharmacol Ther
; 200: 135-147, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077689
15.
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies.
Nat Genet
; 51(10): 1450-1458, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570896
16.
Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.
Drugs
; 77(12): 1313-1336, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28616845
17.
Erratum to "Prognostic factors in patients with oligometastatic breast cancer - A systematic review". [Cancer treatment Rev. 91 (2020) 102114].
Cancer Treat Rev
; 92: 102138, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33342599
18.
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer-Reply.
JAMA Oncol
; 6(8): 1300, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32496508
19.
Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?
Cureus
; 7(12): e433, 2015 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26848422